v3.26.3
Borrowings
9 Months Ended
Sep. 30, 2026
Borrowings [Abstract]  
Borrowings Note 13 – Borrowings

Our Company’s borrowings at September 30, 2026 and December 31, 2025, net of deferred financing costs and including the impact of interest rate derivatives on effective interest rates, are summarized below:

As of September 30, 2026

(Dollars in thousands)

Maturity Date

Contractual
‎
Facility

Balance,
‎
Gross

Balance,
‎
Net(1)

Stated
‎
Interest Rate

Effective
‎
Interest
‎
Rate

Denominated in USD

Trust Preferred Securities (US)

April 30, 2027

$

27,913 

$

27,913 

$

27,783 

8.10%

8.10%

Bank of America Credit Facility (US)

December 21, 2026

5,200 

5,200 

5,198 

13.50%

13.50%

Cinemas 1, 2, 3 Term Loan (US)

October 1, 2026

19,073 

19,073 

19,073 

9.18%

9.18%

Minetta & Orpheum Theatres Loan (US)

(2)

October 1, 2026

6,181 

6,181 

6,141 

7.00%

7.00%

Union Square Financing (US)

(3)

November 6, 2026

49,000 

47,421 

47,375 

11.06%

11.06%

Nationwide Theaters Corp. (US)

(4)

September 30, 2035

13,648 

13,648 

7,896 

4.75%

12.66%

Denominated in foreign currency ("FC")

(5)

NAB Corporate Term Loan (AU)

July 31, 2030

63,609 

63,609 

63,359 

5.90%

5.90%

$

184,624 

$

183,045 

$

176,825 

(1)Net of deferred financing costs amounting to $470,000 and debt discounts (4).

(2)On November 10, 2026, we refinanced this loan with ConnectOne. As we executed this amendment after the balance sheet date but before the issuance of this Form 10-Q, we carry the debt as non-current.

(3)On November 6, 2026 we extended this loan by one year to November 6, 2027. As we executed this amendment after the balance sheet date but before the issuance of this Form 10-Q, we carry the debt as non-current.

(4)This debt is carried net of debt discounts of $5.8 million. We recorded this debt at fair value as a consequence of the acquisition of Sutton Hill Associates. The 12.66% effective interest rate takes into account its fair value at acquisition date, its below market coupon rate and its unsecured nature.

(5)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of September 30, 2026.

As of December 31, 2025

(Dollars in thousands)

Maturity Date

Contractual
‎
Facility

Balance,
‎
Gross

Balance,
‎
Net(1)

Stated
‎
Interest
‎
Rate

Effective
‎
Interest
‎
Rate

Denominated in USD

Trust Preferred Securities (US)

April 30, 2027

$

27,913 

$

27,913 

$

27,617 

8.10%

8.10%

Bank of America Credit Facility (US)

September 18, 2026

6,200 

6,200 

6,200 

10.75%

10.75%

Cinemas 1, 2, 3 Term Loan (US)

October 1, 2026

19,841 

19,841 

19,766 

9.46%

9.46%

Minetta & Orpheum Theatres Loan (US)

June 1, 2026

6,829 

6,829 

6,819 

7.00%

7.00%

Union Square Financing (US)

(2)

November 6, 2026

49,000 

46,641 

46,184 

10.87%

10.87%

Nationwide Theaters Corp. (US)

(3)

September 30, 2035

13,648 

13,648 

7,648 

4.75%

12.66%

Denominated in foreign currency ("FC")

(4)

NAB Corporate Term Loan (AU)

July 31, 2030

64,019 

64,019 

63,732 

5.25%

5.25%

Total

$

187,450 

$

185,091 

$

177,966 

(1)Net of deferred financing costs amounting to $1.1 million and debt discounts (3).

(2)This loan has an option to extend for one year, which is within our control and we intend to exercise.

(3)This debt is carried net of debt discounts of $6.0 million. We recorded this debt at fair value as a consequence of the acquisition of Sutton Hill Associates. The 12.66% effective interest rate takes into account its fair value at acquisition date, its below market coupon rate and its unsecured nature.

(4)The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on exchange rates as of December 31, 2025.

Our loan arrangements are presented, net of the deferred financing costs, on the face of our consolidated balance sheet as follows:

September 30,

December 31,

Balance Sheet Caption (Dollars in thousands)

2026

2025

Debt - current portion

$

27,219

$

35,999

Debt - long-term portion

121,823

114,350

Subordinated debt - current portion

27,783

—

Subordinated debt - long-term portion

—

27,617

Total borrowings

$

176,825

$

177,966

Trust Preferred Securities

Our $27.9 million Trust Preferred Securities loan matures on April 30, 2027. Interest is charged quarterly at 4.0% above SOFR. Interest payments for this loan are required every three months, with the face value of the loan payable on maturity. We have retained an advisor to advise us as to our strategic alternatives.

Minetta and Orpheum Theatres Loan

Our $6.2 million loan with Santander Bank matured on October 1, 2026. It is secured by our Minetta and Orpheum Theatres and carries an interest rate of 7.0%. The loan requires various paydowns throughout the year and a final repayment of $6.2 million upon maturity. While the loan had a maturity date of June 1, 2026, we continued making payments on the same terms and then, in August 2026, we extended the loan’s maturity to October 1, 2026.

On November 10, 2026, we refinanced this loan with ConnectOne. The new loan carries an interest rate of 7.125% and a maturity date of December 1, 2036. We increased the loan balance to $7.0 million. As we executed this amendment after the balance sheet date but before the issuance of this Form 10-Q, we carry the debt as non-current.

Bank of America Credit Facility

As of September 30, 2026, our $5.2 million Bank of America facility is due to mature on December 21, 2026, having extended the maturity date on December 29, 2025, to September 18, 2026, and on June 12, 2026, to December 21, 2026. Interest is charged at 3.5% above the Bank of America Prime rate, which itself has a floor of 1.0%. Payment-in-kind interest at a rate of 0.5% commenced on January 1, 2024, and continued until December 31, 2024, increasing to 1.5% on January 1, 2025, until the facility is repaid in full. This loan is subject to mandatory repayment out of a portion of the net proceeds realized by us in the event that we sell certain specified assets.

On October 30, 2026, we repaid this loan and payment-in-kind interest in full with a portion of the proceeds from the sale of Cinemas 1,2,3.

Cinemas 1,2,3 Term Loan

As of September 30, 2026, our $19.1 million Cinemas 1,2,3 Term Loan with Valley National Bank matures on October 1, 2026. It carries an interest rate of 5.5% above monthly SOFR, with a floor of 7.50% and matures on October 1, 2026.

On October 30, 2026, we repaid this loan in full with a portion of the proceeds of the sale of Cinemas 1,2,3.

Union Square Financing

Our $49.0 million loan facility with Emerald Creek Capital is secured by our 44 Union Square property and certain limited guarantees. It bears a variable interest rate of term SOFR plus 6.9% and includes provisions for a prepaid interest reserve fund.

On May 2, 2025, we extended the maturity date of this loan to November 6, 2026, with one option to extend further to May 6, 2027. The extension provided for a principal payment of $500,000 on or before the maturity date. This modification and a subsequent repayment reduced the facility limit from $55.0 million to $49.0 million. In September 2026 we drew down $1.2 million of this facility to fund certain tenant improvements.

On November 6, 2026 we executed a one year extension to this loan, taking its ultimate maturity to November 6, 2027. The extension provides for a reduced interest rate, and a collateral reserve of $8.0 million. As we executed this amendment after the balance sheet date but before the issuance of this Form 10-Q, we carry the debt as non-current.

Nationwide Theaters Corp.

At the time of our acquisition of Sutton Hill Associates (“SHA”) on December 19, 2025, SHA held $13.6 million of notes payable to Nationwide Theaters Corp. The notes are due in full on September 30, 2035, with interest of 4.75% per annum paid on a quarterly basis. Acquired as part of the Sutton Hill Acquisition, we carry this debt at its calculated fair value of $7.6 million as of acquisition date, with an effective interest rate of 12.66% accreting to its face value over time of $13.6 million.

Debt denominated in foreign currencies

Australian NAB Corporate Term Loan (AU)

Our $63.6 million Revolving Corporate Markets Loan Facility with National Australia Bank (“NAB”) matures on July 31, 2030. It consists of (i) an AU$100.0 million Corporate Loan facility at 1.75% above BBSY, of which AU $60.0 million was revolving and AU$40.0 million was core and (ii) a Bank Guarantee Facility of AU$3.0 million at a rate of 1.9% per annum. AU$50.0 million of the Corporate Loan Facility remains subject to an Interest Rate Collar which has a floor of 4.18% and a cap of 4.78%.

On November 12, 2025, we extended the maturity of this loan to its current maturity date of July 31, 2030.